Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Storch

Showing results (1-10 of 301) with videos related to

Pageof 31
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Neural stem cells and neurodegenerationAlexander Storch, Johannes Schwarz
Translational Research : the Journal of Laboratory and Clinical Medicine|February 5, 2010
Transplantation in Parkinson's disease: will mesenchymal stem cells help to reenter the clinical arena?Johannes Schwarz, Alexander Storch
Expert Opinion on Pharmacotherapy|October 22, 2008
Orally disintegrating selegiline for the treatment of Parkinson's diseaseMatthias Löhle, Alexander Storch
Journal of Neurology|March 26, 2011
Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?Kai Loewenbrück, Alexander Storch
International Review of Neurobiology|August 15, 2017
Nonmotor Fluctuations in Parkinson's DiseaseChristiana Franke, Alexander Storch
Frontiers in Cell and Developmental Biology|April 4, 2022
Hyperoxygenation During Mid-Neurogenesis Accelerates Cortical Development in the Fetal Mouse BrainFranz Markert, Alexander Storch
Journal of Neurology|January 11, 2003
Neural stem cells and Parkinson's diseaseAlexander Storch, Johannes Schwarz
Archives of Gerontology and Geriatrics|October 7, 2008
Tolcapone in elderly patients with Parkinson's disease: a prospective open-label multicenter non-interventional trialGeorg Ebersbach, Alexander Storch
Stem Cells (Dayton, Ohio)|August 23, 2008
Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis?Andreas Hermann, Alexander Storch
Journal of Neural Transmission (Vienna, Austria : 1996)|July 16, 2013
Recent perspectives in neurologyTjalf Ziemssen, Alexander Storch
Pageof 31

Showing results (1-10 of 301) with videos related to

Sort By:
Pageof 31
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Neural stem cells and neurodegenerationAlexander Storch, Johannes Schwarz
Translational Research : the Journal of Laboratory and Clinical Medicine|February 5, 2010
Transplantation in Parkinson's disease: will mesenchymal stem cells help to reenter the clinical arena?Johannes Schwarz, Alexander Storch
Expert Opinion on Pharmacotherapy|October 22, 2008
Orally disintegrating selegiline for the treatment of Parkinson's diseaseMatthias Löhle, Alexander Storch
Journal of Neurology|March 26, 2011
Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?Kai Loewenbrück, Alexander Storch
International Review of Neurobiology|August 15, 2017
Nonmotor Fluctuations in Parkinson's DiseaseChristiana Franke, Alexander Storch
Frontiers in Cell and Developmental Biology|April 4, 2022
Hyperoxygenation During Mid-Neurogenesis Accelerates Cortical Development in the Fetal Mouse BrainFranz Markert, Alexander Storch
Journal of Neurology|January 11, 2003
Neural stem cells and Parkinson's diseaseAlexander Storch, Johannes Schwarz
Archives of Gerontology and Geriatrics|October 7, 2008
Tolcapone in elderly patients with Parkinson's disease: a prospective open-label multicenter non-interventional trialGeorg Ebersbach, Alexander Storch
Stem Cells (Dayton, Ohio)|August 23, 2008
Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis?Andreas Hermann, Alexander Storch
Journal of Neural Transmission (Vienna, Austria : 1996)|July 16, 2013
Recent perspectives in neurologyTjalf Ziemssen, Alexander Storch
Pageof 31